Hangzhou Tigermed Consulting Co (SZSE:300347) GF Score : 90/100 (As of Jun. 06, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co GF Score?

Hangzhou Tigermed Consulting Co has the GF Score of 90, which implies that the company might have Good outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 9/10
3. Growth Rank : 10/10
4. GF Value Rank : 2/10
5. Momentum Rank : 10/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Hangzhou Tigermed Consulting Co might have Good outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Hangzhou Tigermed Consulting Co's GF Score

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Tigermed Consulting Co's GF Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's GF Score distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's GF Score falls into.

Hangzhou Tigermed Consulting Co (SZSE:300347) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Hangzhou Tigermed Consulting Co GF Score Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

HNGZY:USA 03347:Hong Kong

Address

Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053

Website

https://www.tigermed.net

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Executives

	Directors, executives
Cao Xiao Chun	Directors, executives
	Executives
Ye Xiao Ping	Director
Shi Xiao Li	Supervisors
Wang Xiao Bo	Supervisors
Li Xiao Ri	Securities Affairs Representative
Xu Jia Lian	Executives
Gong Yan Hua	Director

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines